These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 10573510

  • 21. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
    Huang WB, Shi LH, Zhu XQ, Xu GX, Qi Q.
    Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
    [Abstract] [Full Text] [Related]

  • 22. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients.
    Yonezawa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y, Tanaka S, Hollingsworth MA, Siddiki B, Kim YS, Sato E.
    Hum Pathol; 1997 Mar; 28(3):344-52. PubMed ID: 9042800
    [Abstract] [Full Text] [Related]

  • 23. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T, Kano M, Koike N, Fukao K, Tanaka N, Todoroki T.
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [Abstract] [Full Text] [Related]

  • 24. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
    Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.
    Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
    [Abstract] [Full Text] [Related]

  • 25. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
    Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA.
    J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
    [Abstract] [Full Text] [Related]

  • 26. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK, Paik YH, Park JY, Park KH, Bang S, Park SW, Chung JB, Park YN, Song SY.
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [Abstract] [Full Text] [Related]

  • 27. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M.
    Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
    [Abstract] [Full Text] [Related]

  • 28. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 29. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 30. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
    Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, Shirabe K, Maehara Y, Oda Y.
    Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
    [Abstract] [Full Text] [Related]

  • 31. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma.
    Boonla C, Wongkham S, Sheehan JK, Wongkham C, Bhudhisawasdi V, Tepsiri N, Pairojkul C.
    Cancer; 2003 Oct 01; 98(7):1438-43. PubMed ID: 14508831
    [Abstract] [Full Text] [Related]

  • 33. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
    Terashi T, Aishima S, Taguchi K, Asayama Y, Sugimachi K, Matsuura S, Shimada M, Maehara S, Maehara Y, Tsuneyoshi M.
    Liver Int; 2004 Feb 01; 24(1):38-45. PubMed ID: 15101999
    [Abstract] [Full Text] [Related]

  • 34. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM.
    Cancer Detect Prev; 2004 Feb 01; 28(5):313-8. PubMed ID: 15542253
    [Abstract] [Full Text] [Related]

  • 35. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC, Hsu C, Kao HL, Jeng YM.
    Cancer Lett; 2006 Apr 08; 235(1):34-9. PubMed ID: 16125303
    [Abstract] [Full Text] [Related]

  • 36. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.
    Yamasaki S.
    J Hepatobiliary Pancreat Surg; 2003 Apr 08; 10(4):288-91. PubMed ID: 14598147
    [Abstract] [Full Text] [Related]

  • 37. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation.
    Takanami K, Yamada T, Tsuda M, Takase K, Ishida K, Nakamura Y, Kanno A, Shimosegawa T, Unno M, Takahashi S.
    Abdom Imaging; 2011 Aug 08; 36(4):447-56. PubMed ID: 20959978
    [Abstract] [Full Text] [Related]

  • 38. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM, Zhu XZ, Ji Y, Hou J.
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov 08; 37(11):749-53. PubMed ID: 19094709
    [Abstract] [Full Text] [Related]

  • 39. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov 08; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

  • 40. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K.
    J Surg Oncol; 2004 Aug 01; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.